Kedilerin Kalp Kası Hastalıkları

Bilal, T. (2011). Köpek ve Kedilerde Kardiyoloji. İstanbul: Nobel Tıp Kitabevleri Ltd. Şti.

Chetboul, V. (2000). Feline Myocardial Diseases. In S. J. Ettinger, E. C. Feldman, & E. Côté (Eds.), Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat (8th ed., pp. 3092–3141). Philadelphia: W.B. Saunders Co.

Ettinger, S. J., Feldman, E. C., & Cote, E. (2024). Ettinger's textbook of veterinary internal medicine (eBook). Elsevier. https://books.google.com.tr/books?id=zHPsEAAAQBAJ

Ferasin, L., Sturgess, C. P., Cannon, M. J., Caney, S. M., Gruffydd-Jones, T. J., & Wotton, P. R. (2003). Feline idiopathic cardiomyopathy: A retrospective study of 106 cats (1994–2001). Journal of Feline Medicine and Surgery, 5(3), 151–159. https://doi.org/10.1016/s1098-612x(02)00133-x

Granstrom, S., Nyberg Godiksen, M. T., Christiansen, M., Pipper, C. B., Willesen, J. T., & Koch, J. (2011). Prevalence of hypertrophic cardiomyopathy in a cohort of British Shorthair cats in Denmark. Journal of Veterinary Internal Medicine, 25, 866–871.

Häggström, J., Luis Fuentes, V., & Wess, G. (2015). Screening for hypertrophic cardiomyopathy in cats. Journal of Veterinary Cardiology, 17(Suppl 1), S134–S149.

Kittleson, M. D., & Côté, E. (2021). Cardiomyopathies other than HCM. Journal of Feline Medicine and Surgery, 23, 1053-1067.

Kittleson, M. D., & Côté, E. (2021). The feline cardiomyopathies 2: Hypertrophic cardiomyopathy. Journal of Feline Medicine and Surgery, 23, 1028–1051.

Kittleson, M. D., & Côté, E. (2021). The feline cardiomyopathies: 3. Cardiomyopathies other than HCM. Journal of Feline Medicine and Surgery, 23(11), 1053–1067. https://doi.org/10.1177/1098612x211030218

Kittleson, M. D., Meurs, K. M., & Harris, S. P. (2015). The genetic basis of hypertrophic cardiomyopathy in cats and humans. Journal of Veterinary Cardiology, 17(Suppl 1), S53–S73.

Kittleson, M. D., Meurs, K. M., Munro, M. J., et al. (1999). Familial hypertrophic cardiomyopathy in Maine Coon cats: An animal model of human disease. Circulation, 99, 3172–3180.

Locatelli, C., Pradelli, D., Campo, G., Spalla, I., Savarese, A., Brambilla, P. G., & Bussadori, C. (2018). Survival and prognostic factors in cats with restrictive cardiomyopathy: A review of 90 cases. Journal of Feline Medicine and Surgery, 20(12), 1138–1143. https://doi.org/10.1177/1098612x18755955

Luis Fuentes, V., Abbott, J., Chetboul, V., Côté, E., Fox, P. R., Häggström, J., Kittleson, M. D., Schober, K., & Stern, J. A. (2020). ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. Journal of Veterinary Internal Medicine, 34(3), 1062–1077. https://doi.org/10.1111/jvim.15745

Nelson, R. W., & Couto, C. G. (2019). Small animal internal medicine (eBook). Elsevier. https://books.google.com.tr/books?id=kh6vDwAAQBAJ

Payne, J. R., Borgeat, K., Connolly, D. J., Boswood, A., Dennis, S., Wagner, T., Menaut, P., Maerz, I., Evans, D., Simons, V. E., Brodbelt, D. C., & Luis Fuentes, V. (2013). Prognostic indicators in cats with hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine, 27, 1427–1436.

Schober, K., Savino, S., & Yildiz, V. (2017). Reference intervals and allometric scaling of two-dimensional echocardiographic measurements in 150 healthy cats. Journal of Veterinary Medical Science, 79, 1764–1771. https://doi.org/10.1292/jvms.17-0250

Schober, K. E., Rush, J. E., Luis Fuentes, V., Glaus, T., Summerfield, N. J., Wright, K., Lehmkuhl, L., Wess, G., Sayer, M. P., Loureiro, J., MacGregor, J., & Mohren, N. (2021). Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study. Journal of Veterinary Internal Medicine, 35, 789–800. https://doi.org/10.1111/jvim.16054

Seo, J., Payne, J. R., Novo Matos, J., Fong, W. W., Connolly, D. J., & Luis Fuentes, V. (2020). Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine, 34, 1718–1727. https://doi.org/10.1111/jvim.15807

Smith, S., Tobias, A., Fine, D., et al. (2004). Corticosteroid-associated congestive heart failure in 12 cats. International Journal of Applied Research in Veterinary Medicine, 2, 159–170.

Turgut, K. (2017). Klinik kedi ve köpek kardiyolojisi. Nobel Tıp Kitabevi.

Ware, W. A., & Ward, J. L. (2022). Kardiyovasküler Sistem Bozuklukları. In R. W. Nelson & C. G. Couto (Eds.), Küçük Hayvan İç Hastalıkları (pp. 1–240). Elsevier Ltd.

Ward, J. L., Kussin, E. Z., Tropf, M. A., Tou, S. P., DeFrancesco, T. C., & Keene, B. W. (2020). Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy. Journal of Veterinary Internal Medicine, 34, 2211–2222.

Wolf, O. A., Imgrund, M., & Wess, G. (2017). Echocardiographic assessment of feline false tendons and their relationship with focal thickening of the left ventricle. Journal of Veterinary Cardiology, 19(1), 14–23. https://doi.org/10.1016/j.jvc.2016.08.008